SCHEDULE 13G: Streeterville Capital Discloses 9.1% Stake in BIO-key International
Beneficial Ownership Report
Streeterville Capital LLC, along with Streeterville Management LLC and John M. Fife, has disclosed a beneficial ownership of 9.1% in BIO-key International Inc.'s common stock.
Summary
- Streeterville Capital LLC, Streeterville Management LLC, and John M. Fife have filed a Schedule 13G, indicating beneficial ownership in BIO-key International Inc.
- The filing reports an aggregate beneficial ownership of 340,000 shares of BIO-key International Inc. Common Stock.
- This ownership represents 9.1% of the outstanding Common Stock, based on 3,736,350 shares outstanding.
- Streeterville Capital LLC directly owns the shares, while Streeterville Management LLC and John M. Fife indirectly beneficially own them.
- The event requiring this filing occurred on January 15, 2025.
- The reporting persons certify that the securities were not acquired or held for the purpose of changing or influencing the control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11.
Sentiment
Score: 5
Explanation: Neutral, as this is a factual disclosure of beneficial ownership and does not contain performance or strategic information that would indicate positive or negative sentiment.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of a significant ownership stake by an investment entity in a publicly traded company. It does not provide specific insights into broader industry trends but indicates an investor's position in the identity and access management sector, where BIO-key International operates.
Stakeholder Impact
- Shareholders: Disclosure of a significant stake by an investment entity can influence market perception and potentially the stock price, as it signals an investor's confidence or strategic interest in the company.
Key Dates
| Date | Description |
|---|---|
| 01/15/2025 | Date of event which requires filing of this statement, indicating the point at which the beneficial ownership threshold was met. |
Keywords
BIO-key International, Streeterville Capital, Schedule 13G, Beneficial Ownership, Common Stock, Equity Stake, Investment, SEC Filing, Shareholder Disclosure
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.